Febrile neutropenia risk factors in actively treated diffuse large B-cell lymphoma patients

Febrile neutropenia risk factors in actively treated diffuse large B-cell lymphoma patients

BACKGROUND: Febrile neutropenia (FN) is a serious problem, especially in hematologic malignancies, and can cause high mortality rates and it occurs in 10%–20% of patients with lymphoma. The aim of this research is to assess the risk factors for FN, and the impact of FN on overall survival (OS) in pa...

Full description

Bibliographic Details
Main Authors: Mehmet Bakirtas, Tuğçe Nur Yiğenoğlu, Semih Başci, Bahar Uncu Ulu, Samet Yaman, Merih Kizil Çakar, Mehmet Sinan Dal, Fevzi Altuntaş
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Iraqi Journal of Hematology
Subjects:
diffuse large b-cell lymphoma
febrile neutropenia
neutropenic fever
r-chop
Online Access:http://www.ijhonline.org/article.asp?issn=2072-8069;year=2022;volume=11;issue=1;spage=7;epage=12;aulast=Bakirtas

Internet

http://www.ijhonline.org/article.asp?issn=2072-8069;year=2022;volume=11;issue=1;spage=7;epage=12;aulast=Bakirtas

Similar Items